BHC
ANALYST COVERAGE36 analysts
HOLD
+49.8%upside to target
Buy
1953%
Hold
1336%
Sell
411%
19 Buy (53%)13 Hold (36%)4 Sell (11%)
Full report →
PRICE
Prev Close
5.42
Open
5.42
Day Range5.33 – 5.48
5.33
5.48
52W Range4.41 – 8.69
4.41
8.69
22% of range
VOLUME & SIZE
Avg Volume
1.9M
FUNDAMENTALS
P/E Ratio
-1.6x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.33
Market-like
TECHNICAL
RSI (14)
46
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 115 days
Sep 10
Key MetricsTTM
Market Cap$2.02B
Revenue TTM$10.55B
Net Income TTM-$1.19B
Free Cash Flow$989.53M
Gross Margin61.7%
Operating Margin22.9%
Net Margin-11.3%
Return on Equity120.7%
Return on Assets-4.9%
Debt / Equity-10.10
Current Ratio1.32
EPS TTM$-3.19

BHC News

About

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Thomas J. Appio
Country
CA
Jiny KimSenior Vice President of Solta Medical
Kathleen FitzpatrickExecutive Vice President and Chief HR & Communications Officer
Jonathan SadehExecutive Vice President, Chief Medical Officer and Head of R&D
Garen SarafianVice President & Head of Investor Relations
Jean-Jacques CharhonExecutive Vice President & Chief Financial Officer
Mirza DautbegovicExecutive Vice President & Chief Operating Officer
Thomas J. AppioChief Executive Officer & Director
William WoodfieldSenior Vice President & Treasurer
Aimee J. LenarExecutive Vice President of US Pharma
Seana CarsonExecutive Vice President & General Counsel
Steven LeeSenior Vice President, Controller & Chief Accounting Officer
Cees HeimanSenior Vice President of Europe & Canada